Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Wall Street Data Solutions Rating
Neutral
B
XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB)
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
09/01/2005
Market Cap
15,109,500
Shares Outstanding
544,910,000
Weighted SO
5,449,061
Total Employees
N/A
Upcoming Earnings
N/A
Similar Tickers
Beta
0.9350
Last Div
0.0000
Range
0.75-4.99
Chg
-0.1100
Avg Vol
17120
Mkt Cap
15109500
Exch
NASDAQ
Country
IL
Phone
972 3 611 6600
DCF Diff
2.4229
DCF
0.2571
Div Yield
0.0000
P/S
0.0000
EV Multiple
39.7776
P/FV
5.3987
Div Yield %
0.0000
P/E
-38.6336
PEG
-0.3866
Payout
0.0000
Current Ratio
11.4260
Quick Ratio
11.4260
Cash Ratio
4.7892
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
0.0000
CCC
0.0000
Gross Margin
0.0000
Op Margin
0.0000
Pretax Margin
0.0000
Net Margin
0.0000
Eff Tax Rate
-2.1138
ROA
-0.1291
ROE
-0.1491
ROCE
-0.2547
NI/EBT
1.0000
EBT/EBIT
0.5486
EBIT/Rev
0.0000
Debt Ratio
0.0000
D/E
0.0000
LT Debt/Cap
0.0000
Total Debt/Cap
0.0000
Int Coverage
-9.0658
CF/Debt
0.0000
Equity Multi
1.0824
Rec Turnover
0.0000
Pay Turnover
0.0000
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0000
OCF/Share
0.0000
FCF/Share
0.0000
Cash/Share
0.4292
OCF/Sales
0.0000
FCF/OCF
0.0000
CF Coverage
0.0000
ST Coverage
0.0000
CapEx Coverage
0.0000
Div&CapEx Cov
0.0000
P/BV
5.3987
P/B
5.3987
P/S
0.0000
P/E
-38.6336
P/FCF
0.0000
P/OCF
0.0000
P/CF
0.0000
PEG
-0.3866
P/S
0.0000
EV Multiple
39.7776
P/FV
5.3987
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | XXXXX | ▲ XXXXX | ▼ XXXXX | ▲ XXXXXXX | ▼ -XXXXXX | ▲ 0.00 | 0.00 |
Cost Of Revenue | X | X | X | X | X | 0.00 | 0.00 |
Gross Profit | XXXXX | ▲ XXXXX | ▼ XXXXX | ▲ XXXXXXX | ▼ -XXXXXX | ▲ 0.00 | 0.00 |
Gross Profit Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | ▼ 0.00 | 0.00 |
Research And Development Expenses | XXXX | ▼ XXXX | ▲ XXXXX | ▼ XXXX | XXXX | 6.00K | 6.00K |
General And Administrative Expenses | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ 169.00K | ▲ 194.00K |
Selling And Marketing Expenses | X | X | X | X | X | 0.00 | 0.00 |
Selling General And Administrative Expenses | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ 169.00K | ▲ 194.00K |
Other Expenses | -XXXX | ▲ X | X | X | X | 0.00 | 0.00 |
Operating Expenses | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ 175.00K | ▲ 200.00K |
Cost And Expenses | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ 175.00K | ▲ 200.00K |
Interest Income | -XXXXXXX | ▲ XXXXX | ▼ -XXXXX | ▲ -XXXX | -XXXX | ▲ 10.00K | ▲ 11.00K |
Interest Expense | -XXXXXXX | ▲ XXXXX | ▲ XXXXX | ▼ XXXX | ▼ -XXXXX | ▲ 16.00K | ▼ 0.00 |
Depreciation And Amortization | -XXXXXXX | ▲ XXXXXX | ▼ -XXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▼ 175.00K | ▼ 0.00 |
Ebitda | -XXXXXXX | ▲ XXXXXX | ▼ -XXXXXX | ▼ -XXXXXXX | ▲ XXXXXX | ▼ -175.00K | ▲ 824.00K |
Ebitda Ratio | -XX.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▼ -XX.XXXXXXXXXX | ▲ -X.XXXXXXXXXX | ▲ -X.XXXXXXXXXX | ▲ 0.00 | 0.00 |
Operating Income | -XXXXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▲ -XXXXXX | ▲ -175.00K | ▼ -200.00K |
Operating Income Ratio | -X.XXXXXXXXX | ▲ -X.XXXXXXXXX | ▼ -X.XXXXXXXXX | ▲ -X.XXXXXXXXX | ▲ X.XXXXXXXXX | ▼ 0.00 | 0.00 |
Total Other Income Expenses Net | XXXXXXX | ▼ -XXXXXX | ▲ XXXXXX | ▲ XXXXXXX | ▼ -XXXXXX | ▲ 660.00K | ▼ -176.00K |
Income Before Tax | XXXXXXX | ▼ -XXXXXXX | ▲ XXXXXX | ▲ XXXXXXX | ▼ -XXXXXX | ▲ 485.00K | ▼ -284.00K |
Income Before Tax Ratio | XX.XXXXXXXXXX | ▼ -XX.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▼ 0.00 | 0.00 |
Income Tax Expense | X | ▼ -XXXXX | ▼ -XXXXX | ▼ -XXXXXXX | ▲ XXXXXX | ▼ -175.00K | ▲ 932.00K |
Net Income | XXXXXXX | ▼ -XXXXXXX | ▲ XXXXXX | ▲ XXXXXXX | ▼ -XXXXXXX | ▲ 485.00K | ▼ -284.00K |
Net Income Ratio | XX.XXXXXXXXXX | ▼ -XX.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▼ 0.00 | 0.00 |
Eps | X.XX | ▼ -X.XX | ▲ -X.XX | ▲ X.XX | ▼ -X.XX | ▲ 0.09 | ▼ -0.05 |
Eps Diluted | X.XX | ▼ -X.XX | ▲ -X.XX | ▲ X.XX | ▼ -X.XX | ▲ 0.09 | ▼ -0.05 |
Weighted Average Shs Out | XXXXXXX | XXXXXXX | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | 5.45M | ▼ 5.45M |
Weighted Average Shs Out Dil | XXXXXXX | XXXXXXX | XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ 5.45M | ▼ 5.45M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ 1.07M | ▲ 1.40M |
Short Term Investments | XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ 1.27M | ▼ 605.00K |
Cash And Short Term Investments | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ 2.34M | ▼ 2.01M |
Net Receivables | X | X | X | X | ▲ XXXXX | ▲ 150.00K | ▼ 29.00K |
Inventory | X | X | X | X | X | 0.00 | 0.00 |
Other Current Assets | XXXXX | ▲ XXXXXX | ▼ XXXXX | ▲ XXXXX | ▼ XXXXX | ▲ 59.00K | ▼ 11.00K |
Total Current Assets | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ 2.55M | ▼ 2.05M |
Property Plant Equipment Net | X | ▲ XXXX | XXXX | ▼ XXXX | ▼ X | 0.00 | 0.00 |
Goodwill | X | X | X | X | X | 0.00 | 0.00 |
Intangible Assets | XXXXXX | XXXXXX | XXXXXX | XXXXXX | XXXXXX | 380.00K | 380.00K |
Goodwill And Intangible Assets | XXXXXX | XXXXXX | XXXXXX | XXXXXX | XXXXXX | 380.00K | 380.00K |
Long Term Investments | X | X | X | X | X | 0.00 | ▼ -604.40K |
Tax Assets | X | X | X | X | X | 0.00 | 0.00 |
Other Non Current Assets | X | X | X | X | X | ▼ -1.00 | ▲ 604.40K |
Total Non Current Assets | XXXXXX | ▲ XXXXXX | XXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▼ 380.00K | ▲ 380.00K |
Other Assets | X | X | X | X | X | ▲ 1.00 | ▼ 0.00 |
Total Assets | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ 2.93M | ▼ 2.43M |
Account Payables | XXXX | ▼ XXXX | ▲ XXXX | XXXX | XXXX | ▲ 223.00K | ▼ 1.00K |
Short Term Debt | X | X | X | X | X | 0.00 | 0.00 |
Tax Payables | X | X | X | X | X | 0.00 | 0.00 |
Deferred Revenue | X | X | X | X | X | 0.00 | 0.00 |
Other Current Liabilities | XXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▼ 0.00 | ▲ 205.00K |
Total Current Liabilities | XXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▲ 223.00K | ▼ 206.00K |
Long Term Debt | X | X | X | X | X | 0.00 | 0.00 |
Deferred Revenue Non Current | X | X | X | X | X | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | X | X | X | X | X | 0.00 | 0.00 |
Other Non Current Liabilities | X | X | X | ▲ XXXXXXX | ▼ XXXX | ▼ 0.00 | 0.00 |
Total Non Current Liabilities | XXXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXX | ▼ 0.00 | 0.00 |
Other Liabilities | -XXXXXXX | ▲ -XXXXXX | ▼ -XXXXXXX | ▲ X | ▼ -XXXX | ▲ 0.00 | 0.00 |
Capital Lease Obligations | X | X | X | X | X | 0.00 | 0.00 |
Total Liabilities | XXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▲ 223.00K | ▼ 206.00K |
Preferred Stock | X | X | X | X | X | 0.00 | ▲ 146.18M |
Common Stock | XXXXXXXX | XXXXXXXX | XXXXXXXX | ▲ XXXXXXXX | XXXXXXXX | 14.12M | 14.12M |
Retained Earnings | -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -157.76M | ▼ -158.25M |
Accumulated Other Comprehensive Income Loss | XXXXX | XXXXX | XXXXX | XXXXX | XXXXX | 20.00K | 20.00K |
Other Total Stockholders Equity | XXXXXXXXX | XXXXXXXXX | XXXXXXXXX | ▼ XXXXXXXXX | XXXXXXXXX | 146.33M | ▼ 146.33K |
Total Stockholders Equity | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ 2.71M | ▼ 2.22M |
Total Equity | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ 2.71M | ▼ 2.22M |
Total Liabilities And Stockholders Equity | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ 2.93M | ▼ 2.43M |
Minority Interest | X | X | X | X | X | 0.00 | 0.00 |
Total Liabilities And Total Equity | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ 2.93M | ▼ 2.43M |
Total Investments | XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ 1.27M | ▼ 605.00 |
Total Debt | X | X | X | X | X | 0.00 | 0.00 |
Net Debt | -XXXXXXX | ▼ -XXXXXXX | ▲ -XXXXXXX | ▲ -XXXXXXX | ▲ -XXXXXXX | ▲ -1.07M | ▼ -1.40M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | XXXX | ▼ -XXX | ▼ -XXXX | ▲ XXXX | ▼ -XXXXXX | ▲ 485.00K | ▼ -284.00K |
Depreciation And Amortization | -XXXX | -XXXX | ▲ -XXXX | ▲ X | X | 0.00 | 0.00 |
Deferred Income Tax | X | X | ▼ -XXXXXX | ▲ X | X | 0.00 | 0.00 |
Stock Based Compensation | XX | ▼ X | ▲ XX | ▼ XX | ▲ XXXXX | ▼ 0.00 | ▲ 3.00K |
Change In Working Capital | -XXXXX | -XXXXX | ▲ XXXXXX | ▼ X | X | 0.00 | 0.00 |
Accounts Receivables | XXXX | XXXX | XXXX | ▼ X | X | 0.00 | 0.00 |
Inventory | X | X | X | X | X | 0.00 | 0.00 |
Accounts Payables | XXXXX | XXXXX | ▲ XXXXX | ▼ X | X | 0.00 | 0.00 |
Other Working Capital | -XXXXX | -XXXXX | ▲ XXXXX | ▼ X | X | 0.00 | 0.00 |
Other Non Cash Items | -XXXX | ▲ XXX | ▲ XXXX | ▼ -XXXX | ▲ XXXXXX | ▼ -485.00K | ▲ 281.00K |
Net Cash Provided By Operating Activities | XXXXXXX | XXXXXXX | ▼ -XXXXXX | ▲ XXXXX | ▼ -XXXXXXX | ▲ 0.00 | 0.00 |
Investments In Property Plant And Equipment | XXXXX | XXXXX | ▼ -XXXX | ▲ X | X | 0.00 | 0.00 |
Acquisitions Net | XXXXX | XXXXX | ▼ X | X | X | 0.00 | 0.00 |
Purchases Of Investments | X | X | X | X | X | 0.00 | 0.00 |
Sales Maturities Of Investments | X | X | X | X | X | 0.00 | 0.00 |
Other Investing Activities | -XXXXX | -XXXXX | ▲ XXXXXXX | ▼ X | X | 0.00 | 0.00 |
Net Cash Used For Investing Activities | XXXXXX | XXXXXX | ▲ XXXXXXX | ▼ X | X | 0.00 | 0.00 |
Debt Repayment | X | X | X | X | X | 0.00 | 0.00 |
Common Stock Issued | -XXXXX | -XXXXX | ▲ X | X | X | 0.00 | 0.00 |
Common Stock Repurchased | X | X | X | X | X | 0.00 | 0.00 |
Dividends Paid | X | X | X | X | X | 0.00 | 0.00 |
Other Financing Activities | X | X | X | X | X | 0.00 | 0.00 |
Net Cash Used Provided By Financing Activities | -XXXXX | -XXXXX | ▲ X | X | X | 0.00 | 0.00 |
Effect Of Forex Changes On Cash | XXXXX | XXXXX | ▼ -XXXX | ▲ X | X | 0.00 | 0.00 |
Net Change In Cash | XXXXXXX | XXXXXXX | ▲ XXXXXXX | ▼ XXXXX | ▼ -XXXXXX | ▲ 0.00 | 0.00 |
Cash At End Of Period | XXXXXXX | XXXXXXX | ▲ XXXXXXX | ▼ XXXXX | ▲ XXXXXXX | ▼ 0.00 | 0.00 |
Cash At Beginning Of Period | XXXXXXX | XXXXXXX | ▲ XXXXXXX | ▼ X | ▲ XXXXXXX | ▼ 0.00 | 0.00 |
Operating Cash Flow | XXXXXXX | XXXXXXX | ▼ -XXXXXX | ▲ XXXXX | ▼ -XXXXXXX | ▲ 0.00 | 0.00 |
Capital Expenditure | XXXXX | XXXXX | ▼ -XXXX | ▲ X | X | 0.00 | 0.00 |
Free Cash Flow | XXXXXXX | XXXXXXX | ▼ -XXXXXX | ▲ XXXXX | ▼ -XXXXXXX | ▲ 0.00 | 0.00 |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Upgrade To Get Access
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Dicta eveniet ex illo maxime minima numquam quibusdam reprehenderit temporibus vel, voluptatum? Delectus eos eveniet id iusto necessitatibus, neque porro unde voluptatibus. Aut blanditiis commodi, iste iure laborum pariatur temporibus. Atque distinctio dolore, doloremque eaque eius harum inventore laudantium quibusdam recusandae voluptatibus.